剂泰科技-P今日盘中股价大跌5.48%，引发了市场的关注。
消息面上，剂泰科技作为全球AI药物递送第一股，近期刚刚完成首次公开募股并上市。然而，公司在上市首日经历大幅上涨后，股价正进入持续回调阶段。这主要由于公司尚处于商业化的早期阶段，过去三年累计亏损约15亿元人民币，营收表现波动，其未来的业绩增长潜力仍需时间来验证。
此外，部分国际配售的股份在上市后并未设置禁售期，这导致了潜在的获利了结压力。随着新股上市初期的市场热度逐渐消退，股价面临的下行压力也随之显现。
剂泰科技-P今日盘中股价大跌5.48%，引发了市场的关注。
消息面上，剂泰科技作为全球AI药物递送第一股，近期刚刚完成首次公开募股并上市。然而，公司在上市首日经历大幅上涨后，股价正进入持续回调阶段。这主要由于公司尚处于商业化的早期阶段，过去三年累计亏损约15亿元人民币，营收表现波动，其未来的业绩增长潜力仍需时间来验证。
此外，部分国际配售的股份在上市后并未设置禁售期，这导致了潜在的获利了结压力。随着新股上市初期的市场热度逐渐消退，股价面临的下行压力也随之显现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.